The role of radiotherapy in HER2+ early-stage breast cancer patients after breast-conserving surgery

BACKGROUND: Due to radioresistance, some HER2+ patients may gain limited benefit from radiotherapy (RT) after breast-conserving surgery (BCS). This study aimed to develop an individualized nomogram to identify early-stage HER2+ patients who could omit RT after BCS. METHODS: The data of HER2+ patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Huanzuo, Qiu, Mengxue, Feng, Yu, Wen, Nan, Zhou, Jiao, Qin, Xiangquan, Li, Juan, Liu, Xinran, Wang, Xiaodong, Du, Zhenggui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845557/
https://www.ncbi.nlm.nih.gov/pubmed/36686782
http://dx.doi.org/10.3389/fonc.2022.903001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845557/
https://www.ncbi.nlm.nih.gov/pubmed/36686782
http://dx.doi.org/10.3389/fonc.2022.903001

Ejemplares similares